why choose us

First received: March 12, 2023

Clinical Trial: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: Characterizing the Radiochemical and Radiation Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Ductal Adenocarcinoma

Brief Summary: The objective of this clinical trial is to determine the safety of an intravenously administered radioisotope, RAD301 ([68Ga]-Trivehexin), in either health volunteers or patients with pancreatic cancer.All subjects will undergo:Screening, which entails physical examination and blood samples for standard blood testing.Subjects that successfully pass screening will undergo:Gallium-68 PET scanning procedures, which will occur during a single day (about 5-6 hours).These subjects will return to the clinic at 2 weeks…

Read more